FGF23 induces left ventricular hypertrophy

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699

Prevalence of Chronic Kidney Disease in the United States

Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837

A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy

Molkentin, J. D., Lu, J., Antos, C. L., Markham, B. E., Richardson, J. A., Robbins, J. M., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566

Fibroblast growth factors.

Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 1,985

Cellular signaling by fibroblast growth factor receptors

Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,923

Regulation of cardiac hypertrophy by intracellular signalling pathways

Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,890

Receptor Specificity of the Fibroblast Growth Factor Family

Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis

Edmonston, D. L., Isakova, T., Dember, L. M., Brunelli, S. M., Young, A., Brosch, R., Beddhu, S., Chakraborty, H., & Wolf, M. S. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.10.008 · Cited by 46

Vascular calcification

Massy, Z. A., & Drüeke, T. B. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328362155b · Cited by 46

FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism

Fukumoto, S. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0029-y · Cited by 46

ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress

Jung, Y. S., Radhakrishnan, K., Hammad, S., Müller, S., Müller, J., Noh, J., Kim, J., Lee, I., Cho, S. J., Kim, D., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103107 · Cited by 45

Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency

Iguchi, A., Kazama, J. J., Yamamoto, S., Yoshita, K., Watanabe, Y., Iino, N., & Narita, I. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000440968 · Cited by 45

Fibroblast Growth Factor 23, High-Sensitivity Cardiac Troponin, and Left Ventricular Hypertrophy in CKD

Smith, K. T., deFilippi, C. R., Isakova, T., Gutiérrez, O. M., Laliberte, K. A., Seliger, S. L., Kelley, W. E., Duh, S., Hise, M. K., Christenson, R. H., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.06.022 · Cited by 45

Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification

Lang, F. J. W., Ritz, E., Alesutan, I., & Voelkl, J. G. J. (2014) · Nephron Physiology · doi:10.1159/000368268 · Cited by 45

Soluble klotho and mortality: The Ludwigshafen Risk and Cardiovascular Health Study

Brandenburg, V. M., Kleber, M. E., Vervloet, M. G., Larsson, T. E., Tomaschitz, A., Pilz, S., Stojaković, T., Delgado, G., Grammer, T. B., Marx, N., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.017 · Cited by 45

Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study

di Giuseppe, R., Kühn, T., Hirche, F., Buijsse, B., Dierkes, J., Fritsche, A., Kaaks, R., Boeing, H., Stangl, G. I., & Weikert, C. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9982-4 · Cited by 45

Cardiovascular Disease Consequences of CKD

Go, A. S. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.006 · Cited by 45

Klotho expression in long bones regulates FGF23 production during renal failure

Kaludjerovic, J., Komaba, H., Sato, T., Erben, R. G., Baron, R., Olauson, H., Larsson, T. E., & Lanske, B. (2017) · The FASEB Journal · doi:10.1096/fj.201601036r · Cited by 45

Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients

Maruyama, N., Otsuki, T., Yoshida, Y., Nagura, C., Kitai, M., Shibahara, N., Tomita, H., Maruyama, T., & Abe, M. (2018) · American Journal of Nephrology · doi:10.1159/000489964 · Cited by 45

FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function

Laszczyk, A. M., Nettles, D., Pollock, T. A., Fox, S. N., Garcia, M. L., Wang, J., Quarles, L. D., & King, G. D. (2019) · eNeuro · doi:10.1523/eneuro.0469-18.2019 · Cited by 46

Distant organ dysfunction in acute kidney injury

Husain‐Syed, F., Rosner, M. H., & Ronco, C. (2019) · Acta Physiologica · doi:10.1111/apha.13357 · Cited by 49

Atherosclerotic Cardiovascular Risk as an Emerging Priority in Pediatrics

Schipper, H. S., & de Ferranti, S. D. (2022) · PEDIATRICS · doi:10.1542/peds.2022-057956 · Cited by 48

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease

Dozio, E., Caldiroli, L., Molinari, P., Castellano, G., Delfrate, N. W., Romanelli, M. M. C., & Vettoretti, S. (2023) · Antioxidants · doi:10.3390/antiox12030584 · Cited by 45

Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways

Curaj, A., Vanholder, R. C., Loscalzo, J., Quach, K., Wu, Z., Jankowski, V., & Jankowski, J. (2024) · Circulation Research · doi:10.1161/circresaha.123.324001 · Cited by 48

Coronary artery calcification in chronic kidney disease: An update

Stompór, T. P. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i4.115 · Cited by 48

Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease

Imazu, M., Takahama, H., Asanuma, H., Funada, A., Sugano, Y., Ohara, T., Hasegawa, T., Asakura, M., Kanzaki, H., Anzai, T., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00331.2014 · Cited by 44

Fibroblast growth factor-23 induces cellular senescence in human mesenchymal stem cells from skeletal muscle

Sato, C., Iso, Y., Mizukami, T., Otabe, K., Sasai, M., Kurata, M., Sanbe, T., Sekiya, I., Miyazaki, A., & Suzuki, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.086 · Cited by 44

αKlotho and Chronic Kidney Disease

Neyra, J. A., & Hu, M. C. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.007 · Cited by 45

A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation

Glosse, P., Fajol, A., Hirche, F., Feger, M., Voelkl, J. G. J., Lang, F. J. W., Stangl, G. I., & Föller, M. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0037-x · Cited by 44

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

Vanholder, R. C., Laecke, S. V., Glorieux, G., Verbeke, F., Castillo-Rodríguez, E., & Ortíz, A. (2018) · Toxins · doi:10.3390/toxins10060237 · Cited by 44

Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study

di Giuseppe, R., Kuhn, T. E., Hirche, F., Buijsse, B., Dierkes, J., Fritsche, A., Kaaks, R., Boeing, H., Stangl, G. I., & Weikert, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133580 · Cited by 45

Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease

Charytan, D. M. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000067 · Cited by 47

Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice

Chen, G., An, N., Shen, J., Chen, H., Chen, Y., Sun, J. M., Hu, Z., Qiu, J., Jin, C., He, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36895-1 · Cited by 43

Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients

Lee, Y., Ng, H., Chiu, T. T., Li, L., Pei, S., Kuo, W., & Lee, C. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.031 · Cited by 43

Fibroblast Growth Factor-23 in Obese, Normotensive Adolescents Is Associated with Adverse Cardiac Structure

Ali, F. N., Falkner, B. E., Gidding, S. S., Price, H. E., Keith, S. W., & Langman, C. B. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.06.027 · Cited by 43

Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation

Boyce, A. M., Bhattacharyya, N., & Collins, M. T. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0144-5 · Cited by 44

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

Fuernau, G. F., Pöss, J., Denks, D., Desch, S., Heine, G. H., Eitel, I., Seiler, S., de Waha, S., Ewen, S., Link, A., et al. (2014) · Critical Care · doi:10.1186/s13054-014-0713-8 · Cited by 43

Blood Pressure, Proteinuria, and Phosphate as Risk Factors for Progressive Kidney Disease: A Hypothesis

Cozzolino, M. G., Gentile, G., Mazzaferro, S., Brancaccio, D., Ruggenenti, P. L., & Remuzzi, G. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.379 · Cited by 43

Effects of dietary phosphate on glucose and lipid metabolism

Abuduli, M., Ohminami, H., Otani, T., Kubo, H., Ueda, H., Kawai, Y., Masuda, M., Yamanaka‐Okumura, H., Sakaue, H., Yamamoto, H., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00234.2015 · Cited by 45

Stop chronic kidney disease progression: Time is approaching

Din, U. A. S. E., Salem, M. M., & Abdulazim, D. O. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i3.258 · Cited by 43

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients

Ketteler, M., Sprague, S. M., Covic, A. C., Rastogi, A., Spinowitz, B., Rakov, V. G., Walpen, S., & Floege, J. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy127 · Cited by 43

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA

Almahmoud, M., Soliman, E., Bertoni, A., Kestenbaum, B., Katz, R., Lima, J., Ouyang, P., Miller, P., Michos, E. D., & Herrington, D. (2018) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.117.008334 · Cited by 41

Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease

Lunyera, J., & Scialla, J. J. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.08.001 · Cited by 43

Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients

Silva, A. P., Mendes, F. B., Carias, E., Gonçalves, R. B., Fragoso, A., Dias, C., Tavares, N., Café, H. M., Santos, N., Rato, F., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071536 · Cited by 43

Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1

Kuga, K., Kusakari, Y., Uesugi, K., Semba, K., Urashima, T., Akaike, T., & Minamisawa, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231905 · Cited by 44

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer

Ewendt, F., Feger, M., & Föller, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.601006 · Cited by 43

Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease

Bansal, N., Zelnick, L. R., Scherzer, R., Estrella, M. M., & Shlipak, M. G. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011173 · Cited by 44

PTH: Potential role in management of heart failure

Gruson, D., Buglioni, A., & Burnett, J. C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.029 · Cited by 44

Therapeutic uses of FGFs

Zhang, J., & Li, Y. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.007 · Cited by 44

Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure

Andersen, I. A., Huntley, B. K., Sandberg, S., Heublein, D. M., & Burnett, J. C. J. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv398 · Cited by 42

Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR

Massicotte‐Azarniouch, D., Kuwornu, J. P., Carrero, J. J., Lam, N. N., Molnar, A. O., Zimmerman, D. L., McCallum, M. K., Garg, A. X., & Sood, M. M. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.08.016 · Cited by 43

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23

Leifheit‐Nestler, M., Richter, B., Basaran, M., Nespor, J., Vogt, I., Alesutan, I., Voelkl, J. G. J., Lang, F. J. W., Heineke, J., Krick, S., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00333 · Cited by 42

Precision Medicine for Nutritional Management in End-Stage Kidney Disease and Transition to Dialysis

Wang, A. Y.-M., Kalantar‐Zadeh, K., Fouque, D. P., ter Wee, P., Kovesdy, C. P., Price, S. R., & Kopple, J. D. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.05.008 · Cited by 42

Intestinal phosphate absorption: The paracellular pathway predominates?

Saurette, M., & Alexander, R. T. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219831220 · Cited by 43

Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD

Lioufas, N. M., Pascoe, E. M., Hawley, C. M., Elder, G. J., Badve, S. V., Block, G. A., Johnson, D. W., & Toussaint, N. D. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021040554 · Cited by 42

Regulation of FGF23: Beyond Bone

Šimić, P., & Babitt, J. L. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00703-w · Cited by 43

Cardiorenal syndrome in chronic kidney disease

Tsuruya, K., & Eriguchi, M. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000099 · Cited by 43

Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study

Jehle, S., Lardi, A. M., Felix, B., Hulter, H. N., Stettler, C., & Krapf, R. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13942 · Cited by 41

Fibroblast Growth Factor‐23 and Frailty in Elderly Community‐Dwelling Individuals: The Cardiovascular Health Study

Beben, T., Ix, J. H., Shlipak, M. G., Sarnak, M. J., Fried, L. F., Hoofnagle, A. N., Chonchol, M., Kestenbaum, B. R., de Boer, I. H., & Rifkin, D. E. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13951 · Cited by 43

Klotho in cardiovascular disease: Current and future perspectives

Donate‐Correa, J. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.351 · Cited by 41

Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder

Hanudel, M. R., & Salusky, I. B. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0365-0 · Cited by 41

Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis

Andrukhova, O., Bayer, J., Schüler, C., Zeitz, U., Murali, S. K., Ada, S., Álvarez‐Pez, J. M., Тихоновна, С. А., & Erben, R. G. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3195 · Cited by 41

Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease

Massy, Z. A., & Liabeuf, S. (2017) · Contributions to nephrology · doi:10.1159/000479252 · Cited by 41

Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy

Mhatre, K. N., Wakula, P., Klein, O., Bisping, E. H., Voelkl, J. G. J., Pieske, B. M., & Heinzel, F. R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2885-x · Cited by 41

Intestinal Phosphorus Absorption in Chronic Kidney Disease

Stremke, E. R., & Gallant, K. M. H. (2018) · Nutrients · doi:10.3390/nu10101364 · Cited by 45

Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children

Bacchetta, J., Bernardor, J., Garnier, C., Naud, C., & Ranchin, B. (2020) · Calcified Tissue International · doi:10.1007/s00223-020-00665-8 · Cited by 52

Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms

Freundlich, M., Gamba, G., & Rodríguez‐Iturbe, B. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04843-6 · Cited by 46

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients

Bell, G. M., Huang, S., Martin, K. J., & Block, G. A. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1031731 · Cited by 40

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

Yan, Z., Wang, G., & Shi, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.785375 · Cited by 49

FGF23 in Acute and Chronic Illness

Schnedl, C., Fahrleitner‐Pammer, A., Pietschmann, P., & Amrein, K. (2015) · Disease Markers · doi:10.1155/2015/358086 · Cited by 40

Potential of vitamin D in treating diabetic cardiomyopathy

Lee, T., Lee, T.-I., Chang, C.-J., Lien, G., Kao, Y., Chao, T., & Chen, Y. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.02.005 · Cited by 41

The osteocyte in CKD: New concepts regarding the role of FGF23 in mineral metabolism and systemic complications

Wesseling‐Perry, K., & Jüppner, H. (2012) · Bone · doi:10.1016/j.bone.2012.10.008 · Cited by 40

Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled

Elewa, U., Sánchez-Niño, M. D., Martín-Cleary, C., Fernández‐Fernández, B., Egido, J., & Ortíz, A. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0271-4 · Cited by 43

Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia

Komaba, H., Kakuta, T., Suzuki, H., Hida, M., Suga, T., & Fukagawa, M. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu335 · Cited by 40

Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels

Knab, V. M., Corbin, B. A., Andrukhova, O., Hum, J. M., Ni, P., Rabadi, S. M., Maeda, A., White, K. E., Erben, R. G., Jüppner, H., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1451 · Cited by 40

The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?

Wu, Y., Zhu, B., Luo, A., Yang, L., & Yang, C. (2018) · BioMed Research International · doi:10.1155/2018/8207058 · Cited by 41

Heart-kidney interactions: mechanistic insights from animal models

Liu, S. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00624.2017 · Cited by 40

Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure

Lkhagva, B., Lin, Y., Kao, Y., Chazo, T.-F., Chung, C., Chen, S.-A., & Chen, Y. (2015) · Pharmacology · doi:10.1159/000438864 · Cited by 40

Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin

Palazzuoli, A., Masson, S., Ronco, C., & Maisel, A. S. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9391-x · Cited by 40

The parathyroid hormone-regulated transcriptome in osteocytes: Parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function

John, H. C. S., Meyer, M. B., Benkusky, N. A., Carlson, A. H., Prideaux, M., Bonewald, L. F., & Pike, J. W. (2014) · Bone · doi:10.1016/j.bone.2014.11.010 · Cited by 39

The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome

Kovesdy, C. P., & Quarles, L. D. (2013) · Nephron Clinical Practice · doi:10.1159/000353593 · Cited by 40

The FGF23/Klotho axis in the regulation of mineral and metabolic homeostasis

Kawai, M. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0068 · Cited by 39

Fibroblast Growth Factor-23—A Potential Uremic Toxin

Kuczera, P., Adamczak, M., & Więcek, A. (2016) · Toxins · doi:10.3390/toxins8120369 · Cited by 39

HIF Activation Against CVD in CKD: Novel Treatment Opportunities

Tanaka, T., & Eckardt, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.006 · Cited by 40

FGF23 Induction of O-Linked N-Acetylglucosamine Regulates IL-6 Secretion in Human Bronchial Epithelial Cells

Krick, S., Helton, E. S., Hutcheson, S. B., Blumhof, S., Garth, J. M., Denson, R. S., Zaharias, R. S., Wickham, H., & Barnes, J. W. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00708 · Cited by 39

Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis

Bortnick, A. E., Xu, S., Kim, R. S., Kestenbaum, B. R., Ix, J. H., Jenny, N. S., de Boer, I. H., Michos, E. D., Thanassoulis, G., Siscovick, D. S., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.215 · Cited by 39

Fibroblast Growth Factor 23 and Long-Term Cardiac Function

Patel, R. B., Ning, H., de Boer, I. H., Kestenbaum, B. R., Lima, J. A. C., Mehta, R. C., Allen, N. B., Shah, S. J., & Lloyd‐Jones, D. M. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.011925 · Cited by 39

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

Tuñón, J., Fernández‐Fernández, B., Carda, R., Pello, A. M., Cristóbal, C., Tarín, N., Aceña, Á., González‐Casaus, M. L., Huelmos, A. I., Alonso, J. J., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2787 · Cited by 39

Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis

Matkar, P. N., Ariyagunarajah, R., Leong-Poi, H. M., & Singh, K. K. (2017) · Biomolecules · doi:10.3390/biom7040074 · Cited by 39

Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis

Vidula, M. K., Orlenko, A., Zhao, L., Salvador, L., Small, A. M., Horton, E., Cohen, J. B., Adusumalli, S., Denduluri, S., Kobayashi, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2361 · Cited by 38

Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy

Bogdanova, E. O., Николаевна, Б. О., Галкина, О. В., Михайловна, З. И., Ivanova, G. T., Parastaeva, M., Semenova, N. Y., & Dobronravov, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094645 · Cited by 37

Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease

Mehta, R. C., Cho, M. E., Cai, X., Lee, J. J., Chen, J., He, J., Flack, J. M., Shafi, T., Saraf, S. L., David, V., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.07.013 · Cited by 40

The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure

Kubin, T., Gajawada, P., Bramlage, P., Hein, S., Berge, B., Çetinkaya, A., Bürger, H., Schönburg, M., Schaper, W. K. A., Choi, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031811 · Cited by 39

Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure

Isakova, T., Houston, J., Santacruz, L., Schiavenato, E., Somarriba, G. A., Harmon, W. G., Lipshultz, S. E., Miller, T. L., & Rusconi, P. G. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2515-7 · Cited by 38

The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers

NasrAllah, M. M., El-Shehaby, A. R., Osman, N. A., Fayad, T., Nassef, A., Salem, M. M., & Din, U. A. S. E. (2013) · Nephron Extra · doi:10.1159/000356118 · Cited by 38

Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients

Morena-Carrere, M., Jaussent, I., Halkovich, A., Dupuy, A., Bargnoux, A., Chénine, L., Leray‐Moragues, H., Klouche, K., Vernhet, H., Canaud, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036175 · Cited by 38

Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner

Bianchi, A., Guibert, M., Cailotto, F., Gasser, A., Presle, N., Mainard, D., Netter, P., Kempf, H., Jouzeau, J., & Reboul, P. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.06.003 · Cited by 38

FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: targeting SDF-1/CXCR4 signaling

Chang, H.-M., Peng, K., Chan, C., Sun, C.-Y., Chen, Y., Chang, H.-M., Huang, C., Liu, P.-C., Chen, P.-Y., Wang, K., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03693-w · Cited by 38

Direct and indirect effects of fibroblast growth factor 23 on the heart

Nakano, T., Kishimoto, H., & Tokumoto, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1059179 · Cited by 39

Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes

Viaene, L., Evenepoel, P., Meijers, B. K. I., Vanderschueren, D., Overbergh, L., & Mathieu, C. (2012) · American Journal of Nephrology · doi:10.1159/000345146 · Cited by 37

The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder

Seifert, M. E., & Hruska, K. A. (2015) · Transplantation · doi:10.1097/tp.0000000000000903 · Cited by 39

Fibroblast growth factor 23 actions in inflammation: a key factor in CKD outcomes

Rossaint, J., Unruh, M. L., & Zarbock, A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw331 · Cited by 42

Fibroblast Growth Factor 23: Mineral Metabolism and Beyond

Grabner, A., Mazzaferro, S., Cianciolo, G., Krick, S., Capelli, I., Rotondi, S., Ronco, C., Manna, G. L., & Faul, C. (2017) · Contributions to nephrology · doi:10.1159/000468952 · Cited by 37

Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets

Takahama, H., & Kitakaze, M. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00215.2017 · Cited by 38

Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD

Krishnasamy, R., Tan, S., Hawley, C. M., Johnson, D. W., Stanton, T., Lee, K., Mudge, D. W., Campbell, S. B., Elder, G. J., Toussaint, N. D., et al. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0705-4 · Cited by 37

Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy

Pereira, R. C., Salusky, I. B., Roschger, P., Klaus Klaushofer, A., Yadin, O., FREYMILLER, E. G., Bowen, R. E., Delany, A. M., Fratzl‐Zelman, N., & Wesseling‐Perry, K. (2018) · Kidney International · doi:10.1016/j.kint.2018.08.011 · Cited by 37

FGF ‐23 dysregulates calcium homeostasis and electrophysiological properties in HL ‐1 atrial cells

Kao, Y., Chen, Y., Lin, Y., Shiu, R., CHAO, T., CHEN, S., & Chen, Y. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12296 · Cited by 37

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease

Leifheit‐Nestler, M., Siemer, R. G., Flasbart, K., Richter, B., Kirchhoff, F., Ziegler, W. H., Klintschar, M., Becker, J. U., Erbersdobler, A., Aufricht, C., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv421 · Cited by 207

Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy

Gutiérrez, O. M. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv445 · Cited by 5

SaO027CARDIO-PATHOLOGICAL EFFECTS OF FGF23 IN CKD ARE MEDIATED BY FGFR4

Grabner, A., Amaral, A. P., Singh, S., Schramm, K. J., Sloan, A. J., Kentrup, D., Reuter, S., Pavenstaedt, H., Marco, G. S. D., Wolf, M., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv150.04

FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD

Hidaka, N., Inoue, K., Katô, H., Hoshino, Y., Koga, M., Kinoshita, Y., Takashi, Y., Makita, N., Fukumoto, S., Nangaku, M., et al. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100747 · Cited by 13

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K. A., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E. E., Christenson, R. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 843